InvestorsHub Logo
icon url

golf stud

11/30/22 10:12 AM

#394649 RE: ilovetech #394648

The only way IMO amarin settles without it being a benefit to the company is that they feel they have no real chance of gaining anything and want to preserve cash. If this isn’t the reason for settlement their has to be a positive gain for the company. Until the terms are disclosed all of this is pure speculation on our parts
icon url

swg_tdr

11/30/22 10:23 AM

#394654 RE: ilovetech #394648

ilove, your appeal to Marjac re stocktwit post -- looks like this man might be right and hence management deems it a "no significant development to post". RATS.
icon url

JRoon71

11/30/22 10:42 AM

#394657 RE: ilovetech #394648

ILT, you have to take Novo1's opinions with a grain of salt. He is incredibly angry and bitter towards Amarin, and has been for years. To the point that it seems to cloud his judgement.

Just saying.
icon url

marjac

11/30/22 3:05 PM

#394678 RE: ilovetech #394648

Novo could be right in his analysis. I personally do not like to speculate on a settlement/document based upon conjecture prior to reviewing the actual terms. It will also be interesting to see what the market thinks of the settlement, if anything.
icon url

Birdbrain Ideas

11/30/22 5:07 PM

#394693 RE: ilovetech #394648

The person on Stock Twits has it all wrong. Amarin's doing the right thing in settling this now. The agreement itself might not be made public, but I imagine there will be some kind of joint statement by the parties that will make it clear that Vascepa will no longer be trampled on by Health Net. Vascepa will be treated equally to generics. Most likely, Amarin is getting what it was demanding when it met with the Health Net rep before filing the lawsuit. It wasn't asking for a lot then, only to be playing on a level playing field against generics. The company was never really seeking financial damages out of this. It wanted a settlement all along, so it can wave the deal in front of other insurance companies.

Going to trial carries all kinds of risks, as we learned with Judge Du. The judge who dismissed Hikma from the lawsuit could more easily have dismissed Health Net down the road, when a judge is not required to view the facts in the most favorable way toward the plaintiff. Meanwhile, settling saves millions of dollars in legal costs, makes the company seem a little cleaner to a potential buyer and likely improves Amarin's standing with larger insurance companies, who might have been a bit spooked by the fact that an insurance company was sued at all.